Pet Medications in the U.S 4th Edition - The Entrance of a Wave of Animal Health Start-ups, and a Number of New Drugs Appear to be on the Horizon are Key Market Drivers

News provided by

Nov 26, 2015, 04:45 ET

DUBLIN, November 26, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/prc9rt/pet_medications) has announced the addition of the "Pet Medications in the U.S., 4th Edition" report to their offering.

Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The market for pet medications in the U.S. has entered a period of redefinition and renewal. Merial's Frontline Plus is still the market leader in flea and tick medication, but it has a number of copycat competitors, selling at far less than the now off-patent powerhouse. But Merial has managed to not only stem the losses, but also gain back share via a new flea and tick blockbuster, Nexgard. In other areas, Zoetis introduced a blockbuster of its own, the anti-itch drug APOQUEL, and has had trouble meeting demand. The industry has also enjoyed the entrance of a wave of animal health start-ups, and a number of new drugs appear to be on the horizon.

The pet medication space has also seen considerable investment action, from the position taken in Zoetis by the hedge fund of activist investor William Ackman to the sale of Novartis Animal Health's assets to Elanco and Virbac.

In its fourth edition, Pet Medications in the U.S. analyzes the market for prescription and over-the-counter medications for dogs and cats, with a particular focus on brand-name products used by consumers and on antiparasitics. Areas covered include parasite prevention and control (flea, tick, heartworm, etc.), cancer, pain management, behavioral health, diabetes, cognitive dysfunction, heart health, ear care and allergies. The report provides in-depth coverage of competitive trends, new product trends and marketing activity, and draws on insights from other reports in Packaged Facts' extensive Pet Market Collection. Statistics provided include historical and projected market revenues, along with demographics and psychographics of pet med purchasers, based on data from sources including Simmons and Packaged Facts own pet owner surveys.

Key Topics Covered:

Chapter 1: Executive Summary

Chapter 2: Market Trends

Chapter 3: The Marketers

Chapter 4: Retail Trends

Chapter 5: Consumer Trends

For more information visit http://www.researchandmarkets.com/research/prc9rt/pet_medications

Media Contact:
Laura Wood
+353-1-481-1716
[email protected]

SOURCE Research and Markets